Cargando…

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015

The fifth “Melanoma Bridge Meeting” took place in Naples, December 1–5th, 2015. The main topics discussed at this meeting were: Molecular and Immuno advances, Immunotherapies and Combination Therapies, Tumor Microenvironment and Biomarkers and Immunoscore. The natural history of cancer involves inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galon, J., Fox, B. A., Bifulco, C. B., Masucci, G., Rau, T., Botti, G., Marincola, F. M., Ciliberto, G., Pages, F., Ascierto, P. A., Capone, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029056/ https://www.ncbi.nlm.nih.gov/pubmed/27650038 http://dx.doi.org/10.1186/s12967-016-1029-z

Ejemplares similares

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
por: Ascierto, Paolo A, et al.
Publicado: (2013)

World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
por: Galon, Jerome, et al.
Publicado: (2017)

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
por: Bifulco, Carlo, et al.
Publicado: (2014)

Immunoscore: a new possible approach for melanoma classification
por: Capone, Mariaelena, et al.
Publicado: (2014)

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
por: Ascierto, Paolo A., et al.
Publicado: (2020)

Immunoprofiling and immunoscoring in cor onary artery disease: From vascular research to the bedside?
por: Bruno, Antonino, et al.
Publicado: (2022)

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
por: Galon, Jérôme, et al.
Publicado: (2014)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
por: Hijazi, Assia, et al.
Publicado: (2023)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5(th) 2015
por: Ascierto, Paolo A., et al.
Publicado: (2016)

Cancer classification using the Immunoscore: a worldwide task force
por: Galon, Jérôme, et al.
Publicado: (2012)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
por: Nassif, Elise F., et al.
Publicado: (2021)

The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020)

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2018)

Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015
por: Nanda, Vashisht G. Y., et al.
Publicado: (2016)

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
por: Willis, Joseph, et al.
Publicado: (2023)

Future perspectives in melanoma research: Meeting report from the “Melanoma Bridge”. Napoli, December 1st–4th 2015
por: Ascierto, Paolo A., et al.
Publicado: (2016)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2023)

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014
por: Ascierto, Paolo A., et al.
Publicado: (2015)

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019
por: Ascierto, Paolo A, et al.
Publicado: (2020)

Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer
por: Marliot, Florence, et al.
Publicado: (2020)

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study
por: Mlecnik, Bernhard, et al.
Publicado: (2022)

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2020)

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
por: Kirilovsky, Amos, et al.
Publicado: (2022)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2019)

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
por: Ascierto, Paolo A., et al.
Publicado: (2022)

The immune score as a new possible approach for the classification of cancer
por: Galon, Jérôme, et al.
Publicado: (2012)

Characterization of anticoagulant heparinoids by immunoprofiling
por: Wijnhoven, Tessa J., et al.
Publicado: (2007)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020)

Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015)

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
por: Kallinteris, Nikoletta L, et al.
Publicado: (2015)

Immunoprofiling of T cell responses in melanoma patients undergoing CPI therapy
por: Talarico, Lee Ann, et al.
Publicado: (2015)

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
por: Baldin, Pamela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ra9lihvkfvoavs9os2b3ahgobr